Search - tctmd.com

Displaying 21 - 40 of 51

Sort: Relevancy | Date

Presentation TCT 2023

Case Presentation: Distal LMCA Bifurcation Disease – The Set Up

Presenter: Jasleen Tiwana

October 25, 2023

Presentation TCT 2023

Case 2 – Left Main Trifurcation Disease: Role of Device Synergy

Presenter: Ashok Seth

October 23, 2023

Presentation TVT 2022

Case 1: Low Left Main and/or LM disease

Presenter: Vivian Ng

June 10, 2022

Presentation CTO 2022

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? Interventional Perspectives

Presenter: Gregg Stone

February 25, 2022

Presentation CTO 2022

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? A Surgeon’s Viewpoint

Presenter: Mario Gaudino

February 25, 2022

Presentation TCT 2021

TCT 101: Long-term Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Treating In-stent Restenosis in Unprotected Left Main Coronary Artery: Multicenter LM-DRAGON Registry

Presenter: Wojciech Wojakowski

November 05, 2021

Presentation SCAI 2020

Outcomes with Intermediate Left Main Disease on Coronary CT Angiography ISCHEMIA Intermediate LM Substudy

Presenter: Sripal Bangalore

May 16, 2020

Presentation Cardiovascular Interventions 2019

PCI Vs CABG for Multivessel and Unprotected LM Disease

Presenter: Paul S. Teirstein

November 01, 2019

Presentation TCT 2019

DEFINE-LM Registry: Revascularization Deferral in Patients With Left Main Coronary Artery Disease Based on iFR Evaluation

Presenter: Takayuki Warisawa

September 28, 2019

Presentation TCT 2019

Case 3: Diabetic Patient — Multivessel Disease With LM (2-Year IVUS Follow-Up)

Presenter: Prathap Kumar

September 28, 2019

Presentation TCT 2019

How to Approach LM Trifurcation Disease

Presenter: Jean Fajadet

September 27, 2019

Presentation TCT 2019

Heart Team Case Discussions for 2 Patients With Left Main Bifurcation Disease

Presenter: Matthew Cavender

September 27, 2019

Presentation TCT 2019

IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease

Presenter: Robert-Jan Van Geuns

September 26, 2019

Presentation JIM 2019

Clinical scenario and context: A stable patient with LM involvement and MV disease

Presenter: Gianluca Campo

February 13, 2019

Presentation CHIP Florida 2019

LMCA and Bifurcation Disease

Presenter: Ajay J. Kirtane

January 26, 2019

Presentation Cardiovascular Interventions 2018

PCI Vs CABG for Multivessel and Unprotected LM Disease

Presenter: Paul S. Teirstein

October 26, 2018

Presentation TCT 2018

SKS Stent Technique for True LM Bifurcation Disease: Advantages and Pitfalls (With Case Examples)

Presenter: Antonio Colombo, Leif Thuesen, Javaid Iqbal

September 23, 2018

Presentation TCT 2018

Case settled: CABG for Most!

Presenter: Robert A. Guyton

September 23, 2018

Presentation TCT 2018

Case Settled: PCI for Most!

Presenter: Marie-Claude Morice

September 23, 2018

Presentation CHIP at ACC 2018

Update on PCI for LMCA and Multivessel Disease

Presenter: Gregg W. Stone

March 09, 2018

Advertisement

Case Presentation: Distal LMCA Bifurcation Disease – The Set Up

Case 2 – Left Main Trifurcation Disease: Role of Device Synergy

Case 1: Low Left Main and/or LM disease

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? Interventional Perspectives

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? A Surgeon’s Viewpoint

TCT 101: Long-term Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Treating In-stent Restenosis in Unprotected Left Main Coronary Artery: Multicenter LM-DRAGON Registry

Outcomes with Intermediate Left Main Disease on Coronary CT Angiography ISCHEMIA Intermediate LM Substudy

PCI Vs CABG for Multivessel and Unprotected LM Disease

DEFINE-LM Registry: Revascularization Deferral in Patients With Left Main Coronary Artery Disease Based on iFR Evaluation

Case 3: Diabetic Patient — Multivessel Disease With LM (2-Year IVUS Follow-Up)

How to Approach LM Trifurcation Disease

Heart Team Case Discussions for 2 Patients With Left Main Bifurcation Disease

IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease

Clinical scenario and context: A stable patient with LM involvement and MV disease

LMCA and Bifurcation Disease

PCI Vs CABG for Multivessel and Unprotected LM Disease

SKS Stent Technique for True LM Bifurcation Disease: Advantages and Pitfalls (With Case Examples)

Case settled: CABG for Most!

Case Settled: PCI for Most!

Update on PCI for LMCA and Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content